loadpatents
name:-0.01186990737915
name:-0.008289098739624
name:-0.0033018589019775
Lange; Christopher Patent Filings

Lange; Christopher

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lange; Christopher.The latest application filed is for "indane-amines as pd-l1 antagonists".

Company Profile
10.13.16
  • Lange; Christopher - El Cerrito CA
  • LANGE; Christopher - Hayward CA
  • Lange; Christopher - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Immunomodulator compounds
Grant 11,426,364 - Lange , et al. August 30, 2
2022-08-30
Indane-amines As Pd-l1 Antagonists
App 20220175746 - LANGE; Christopher ;   et al.
2022-06-09
Triaryl compounds for treatment of PD-L1 diseases
Grant 11,266,643 - Fan , et al. March 8, 2
2022-03-08
Indane-amines as PD-L1 antagonists
Grant 11,135,210 - Lange , et al. October 5, 2
2021-10-05
Immunomodulator Compounds
App 20210147356 - LANGE; Christopher ;   et al.
2021-05-20
Immunomodulator Compounds
App 20210052514 - LANGE; Christopher ;   et al.
2021-02-25
Immunomodulator compounds
Grant 10,919,852 - Lange , et al. February 16, 2
2021-02-16
Compounds For Treatment Of Pd-l1 Diseases
App 20210002229 - MALATHONG; Viengkham ;   et al.
2021-01-07
Triaryl Compounds For Treatment Of Pd-l1 Diseases
App 20200383979 - FAN; Pingchen ;   et al.
2020-12-10
Indane-amines As Pd-l1 Antagonists
App 20200375962 - LANGE; Christopher ;   et al.
2020-12-03
Immunomodulator compounds
Grant 10,639,284 - Lange , et al.
2020-05-05
Indane-amines as PD-L1 antagonists
Grant 10,568,874 - Lange , et al. Feb
2020-02-25
Indane-amines As Pd-l1 Antagonists
App 20190282555 - LANGE; Christopher ;   et al.
2019-09-19
Immunomodulator Compounds
App 20190135745 - LANGE; Christopher ;   et al.
2019-05-09
Immunomodulator Compounds
App 20180008554 - LANGE; Christopher ;   et al.
2018-01-11
Method For Determining Predisposition To Pulmonary Infection
App 20160053321 - Levy; Hara ;   et al.
2016-02-25
Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
Grant 8,802,856 - Ji , et al. August 12, 2
2014-08-12
Quaternary Ammonium Diphenylmethyl Compounds Useful As Muscarinic Receptor Antagonists
App 20140051864 - JI; YuHua ;   et al.
2014-02-20
Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
Grant 8,592,453 - Ji , et al. November 26, 2
2013-11-26
Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
Grant 8,378,121 - Ji , et al. February 19, 2
2013-02-19
Quaternary Ammonium Diphenylmethyl Compounds Useful As Muscarinic Receptor Antagonists
App 20110020231 - JI; YuHua ;   et al.
2011-01-27
Quaternary Ammonium Diphenylmethyl Compounds Useful As Muscarinic Receptor Antagonists
App 20110021787 - JI; YuHua ;   et al.
2011-01-27
Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
Grant 7,834,185 - Ji , et al. November 16, 2
2010-11-16
Method For Determining Predisposition To Pulmonary Infection
App 20090093395 - Levy; Hara ;   et al.
2009-04-09
Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
App 20080207736 - Ji; YuHua ;   et al.
2008-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed